Marlin’s broader portfolio cushions October’s AI-driven market retreat

Marlin Global outperformed its benchmark in October as financial, healthcare and consumer holdings offset sharp falls in Alphabet and Meta. The Fisher Funds-managed portfolio recorded a 0.1% gross return while adjusted NAV slipped 0.1%.

  • Gross portfolio return of +0.1% versus benchmark decline of 0.7%
  • Adjusted NAV fell 0.1% in October; total shareholder return was +9.1%
  • Equifax, Tyler Technologies, Tradeweb and Arthur J Gallagher led gains
  • Alphabet and Meta Platforms fell as investors questioned AI spending and monetisation
  • Portfolio now has 35 or more stocks, with 81% allocated to North America
An image related to Marlin Global Limited A photo of the logo for Marlin Global Add us as a preferred source on Google
Image © middle. Logo © respective owner.

Financial and healthcare holdings soften October market shock

Marlin Global Limited (NZX:MLN) managed a narrow gain against a much rougher month for global equities, posting a gross performance return of 0.1% in October while its benchmark fell 0.7%. Adjusted NAV declined 0.1%. The result came as global equities dropped 1.6% in US dollar terms and the Nasdaq lost about 5%, with investors questioning whether the vast sums committed to artificial intelligence will generate adequate returns.

The month also exposed a sharp change in market leadership. Semiconductors fell 15.4% and communication services dropped 15.2%, while energy, consumer staples and healthcare rose 14.0%, 11.4% and 9.8%, respectively. Marlin’s strongest contributors included Equifax, up 35%, Tyler Technologies, up 24%, Tradeweb Markets, up 22%, and Arthur J Gallagher, up 21%.

Portfolio repositioning starts to show through

The manager said it had significantly repositioned the portfolio in recent months by adding new high-conviction positions and broadening sector and geographic diversification. That effort follows the portfolio guardrails overhaul, which was reported after Marlin’s FY2026 portfolio fell 6.3% while its benchmark gained 30.5%.

New holding Arthur J Gallagher benefited first from stronger-than-expected results at rival Marsh McLennan and then from Gallagher’s own third-quarter report. Gallagher’s net earnings and operating profit each grew by about 25%, while management reaffirmed its full-year growth outlook. S&P Global, another new addition, rose 18% after reporting earnings per share of US$4.58, ahead of forecasts near US$4.42, and lifting its full-year outlook.

AI exposure becomes the month’s main drag

Alphabet was Marlin’s largest detractor, falling 19% after third-quarter revenue of US$127.6 billion came in slightly below forecasts and Google Search growth slowed to 12%. The manager said AI-generated responses are currently monetised at a lower rate than traditional search, although cloud revenue more than doubled and the Gemini app passed one billion monthly users.

Meta Platforms fell 15% despite 26% revenue growth, as a US$9.9 billion legal charge weighed on earnings and quarterly AI spending reached US$34.9 billion. Meta also raised the low end of its 2026 spending forecast to US$135 billion. The update does not provide a forecast for Marlin’s own returns, leaving the portfolio’s ability to maintain its recent relative performance dependent on whether the broader sector rotation persists.

Share price remains below reported NAV

Marlin’s share price was $0.72 at 31 October against an NAV of $0.81, implying a reported discount of 10.7%. The company’s one-month total shareholder return was 9.1%, while adjusted NAV return was negative 0.1%; the former includes share price, warrant and dividend components and is therefore not directly comparable with the portfolio measure. Information technology remained the largest sector allocation at 27%, and North America accounted for 81% of the portfolio.

Get NZX:MLN news the moment it breaks

Instant push notifications No waitlist Free
Download on the App Store iPhone & iPad
Get it on Google Play Android
Email alerts

Bottom Line?

October suggests Marlin’s broader portfolio is providing some protection from the AI-led sell-off, but the next test is whether that relative edge can persist while technology remains its largest sector exposure.

Questions in the middle?

  • Can Marlin’s newer financial, healthcare and consumer holdings continue offsetting weakness in Alphabet and Meta?
  • Will the portfolio’s 27% information technology allocation become a larger drag if AI spending concerns deepen?
  • Can adjusted NAV recover towards the $0.83 high-water mark while the share price remains at a reported discount?

Sources

1